A detailed history of Harvest Investment Services, LLC transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Harvest Investment Services, LLC holds 48,680 shares of ZNTL stock, worth $112,937. This represents 0.04% of its overall portfolio holdings.

Number of Shares
48,680
Holding current value
$112,937
% of portfolio
0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$2.7 - $4.03 $131,436 - $196,180
48,680 New
48,680 $147,000

Others Institutions Holding ZNTL

About Zentalis Pharmaceuticals, Inc.


  • Ticker ZNTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,983,600
  • Market Cap $132M
  • Description
  • Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...
More about ZNTL
Track This Portfolio

Track Harvest Investment Services, LLC Portfolio

Follow Harvest Investment Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Investment Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Investment Services, LLC with notifications on news.